lancet-header

Preprints with The Lancet is part of SSRN´s First Look, a place where journals identify content of interest prior to publication. Authors have opted in at submission to The Lancet family of journals to post their preprints on Preprints with The Lancet. The usual SSRN checks and a Lancet-specific check for appropriateness and transparency have been applied. Preprints available here are not Lancet publications or necessarily under review with a Lancet journal. These preprints are early stage research papers that have not been peer-reviewed. The findings should not be used for clinical or public health decision making and should not be presented to a lay audience without highlighting that they are preliminary and have not been peer-reviewed. For more information on this collaboration, see the comments published in The Lancet about the trial period, and our decision to make this a permanent offering, or visit The Lancet´s FAQ page, and for any feedback please contact preprints@lancet.com.

PTGIS is a Novel Susceptibility Gene for Pulmonary Arterial Hypertension

38 Pages Posted: 3 Dec 2018

See all articles by Xiao-Jian Wang

Xiao-Jian Wang

Chinese Academy of Medical Sciences - Key Laboratory of Pulmonary Vascular Medicine

Xi-Qi Xu

Chinese Academy of Medical Sciences - Key Laboratory of Pulmonary Vascular Medicine

Kai Sun

Chinese Academy of Medical Sciences - Key Laboratory of Pulmonary Vascular Medicine

Ke-Qiang Liu

Chinese Academy of Medical Sciences

Su-Qi Li

Chinese Academy of Medical Sciences - Key Laboratory of Pulmonary Vascular Medicine

Xin Jiang

Chinese Academy of Medical Sciences - Key Laboratory of Pulmonary Vascular Medicine

Qin-Hua Zhao

Tongji University - Shanghai Pulmonary Hospital

Lan Wang

Tongji University - Department of Pulmonary Circulation Medicine; Tongji University - Department of Cardio-Pulmonary Circulation

Fu-Hua Peng

Chinese Academy of Medical Sciences - Key Laboratory of Pulmonary Vascular Medicine

Jue Ye

Chinese Academy of Medical Sciences - Key Laboratory of Pulmonary Vascular Medicine

Yan Wu

Chinese Academy of Medical Sciences - Key Laboratory of Pulmonary Vascular Medicine

Rui Jiang

Tsinghua University

Wei Huang

Chongqing Medical University - Department of Cardiology

Wen-Bin Wei

Sun Yat-sen University (SYSU)

Yi Yan

Chinese Academy of Medical Sciences - Key Laboratory of Pulmonary Vascular Medicine

Jing-Hui Li

Chinese Academy of Medical Sciences - Key Laboratory of Pulmonary Vascular Medicine

Qian-Qian Liu

Chinese Academy of Medical Sciences - Key Laboratory of Pulmonary Vascular Medicine

Sheng Li

ShanghaiTech University

Yong Wang

Capital Medical University

Shu-Yang Zhang

Chinese Academy of Medical Sciences - Peking Union Medical College

Xue Zhang

Chinese Academy of Medical Sciences - Center for Genetic Medicine

Zhi-Cheng Jing

Chinese Academy of Medical Sciences - Key Laboratory of Pulmonary Vascular Medicine; Chinese Academy of Medical Sciences - Peking Union Medical College

More...

Abstract

Background: Genetic variants such as inactivating mutation in the bone morphogenetic protein receptor 2 (BMPR2) gene account for approximately 15-20% of the etiology of idiopathic pulmonary arterial hypertension (IPAH). Increasing evidence indicates the existence of other IPAH susceptibility genes.    

Methods: The whole-genome sequencing was performed in a discovery cohort including 42 IPAH patients who are lacking BMPR2 mutations. Putative IPAH genes were validated in an independent cohort that included 188 IPAH patients and 968 healthy controls. Functional assessments were conducted to analyze the effects of candidate genetic variants on transcript splicing, enzymatic activity and function.  

Results: An enrichment of rare variants in the gene encoding prostacyclin synthase (PTGIS) was initially identified by the whole-genome sequencing. The association of PTGIS rare variants with IPAH was confirmed in the replication cohort. In total, fourteen patients (6.1%) were heterozygous for three PTGIS rare variants, including one splice-site variant (c.521 1G>A) and two missense variants (R252Q, A447T). These rare variants conferred a 7.8-fold greater risk of IPAH (95% confidence interval (CI), 3.2 to 18.8; P=5 x 10-6). Inhaled iloprost induced more significantly decrease of pulmonary vascular resistance (P=0.001) and increase of cardiac index (P< 0.001) in patients with PTGIS variants than those without. The mini-gene assay indicated that the c.521 1G>A variant resulted in aberrant mRNA transcripts. The functional studies showed that the two missense variants caused a decrease in prostacyclin production and increased cell death in pulmonary microvascular endothelial cells.  

Conclusions: We have identified three loss-of-function rare variants in the PTGIS gene from two independent IPAH cohorts. The genetic variants of PTGIS predispose pulmonary vascular responses to the iloprost stimulation and cause deleterious effects. These results provide a novel finding that PTGIS rare variants are involved in the pathogenesis of IPAH.   

Funding: The work was supported by the following grants: the Beijing Natural Science Foundation (7181009, 7172180), the National Natural Science Foundation of China (81320108005), the National Science Fund for Distinguished Young Scholars (81425002), CAMS Innovation Fund for Medical Sciences (2016-I2M-1-002, 2016-I2M-4-003), the National Key Research and Development Program of China (2016YFC0901502), Sanming Project of Medicine in Shenzhen-Professor Zhi-Cheng Jing's Group for Precise Medicine Research in Thrombosis and Vascular Disease (SZSM201502001) , and the fund from State Key Laboratory of Cardiovascular Disease (2016-kf04, 2018ZR-02).

Declaration of Interest: The authors declare no competing financial interests.

Ethical Approval: The study protocol was approved by the ethics committees of Shanghai Pulmonary Hospital and FuWai Hospital. The participants, who were all of Chinese Han ancestry, provided written informed consent.

Keywords: Idiopathic pulmonary arterial hypertension; PTGIS; Genetic rare variant; BMPR2

Suggested Citation

Wang, Xiao-Jian and Xu, Xi-Qi and Sun, Kai and Liu, Ke-Qiang and Li, Su-Qi and Jiang, Xin and Zhao, Qin-Hua and Wang, Lan and Peng, Fu-Hua and Ye, Jue and Wu, Yan and Jiang, Rui and Huang, Wei and Wei, Wen-Bin and Yan, Yi and Li, Jing-Hui and Liu, Qian-Qian and Li, Sheng and Wang, Yong and Zhang, Shu-Yang and Zhang, Xue and Jing, Zhi-Cheng, PTGIS is a Novel Susceptibility Gene for Pulmonary Arterial Hypertension (August 11, 2018). Available at SSRN: https://ssrn.com/abstract=3292608 or http://dx.doi.org/10.2139/ssrn.3292608

Xiao-Jian Wang

Chinese Academy of Medical Sciences - Key Laboratory of Pulmonary Vascular Medicine

Beijing
China

Xi-Qi Xu

Chinese Academy of Medical Sciences - Key Laboratory of Pulmonary Vascular Medicine

Beijing
China

Kai Sun

Chinese Academy of Medical Sciences - Key Laboratory of Pulmonary Vascular Medicine

Beijing
China

Ke-Qiang Liu

Chinese Academy of Medical Sciences

NO. 9, Dongdan Santiao
Beijing, Dongcheng District
China

Su-Qi Li

Chinese Academy of Medical Sciences - Key Laboratory of Pulmonary Vascular Medicine

Beijing
China

Xin Jiang

Chinese Academy of Medical Sciences - Key Laboratory of Pulmonary Vascular Medicine

Beijing
China

Qin-Hua Zhao

Tongji University - Shanghai Pulmonary Hospital

507 Zhengmin Rd
Shanghai, Shanghai Shi
China

Lan Wang

Tongji University - Department of Pulmonary Circulation Medicine

China

Tongji University - Department of Cardio-Pulmonary Circulation

Fu-Hua Peng

Chinese Academy of Medical Sciences - Key Laboratory of Pulmonary Vascular Medicine

Beijing
China

Jue Ye

Chinese Academy of Medical Sciences - Key Laboratory of Pulmonary Vascular Medicine

Beijing
China

Yan Wu

Chinese Academy of Medical Sciences - Key Laboratory of Pulmonary Vascular Medicine

Beijing
China

Rui Jiang

Tsinghua University

Beijing, 100084
China

Wei Huang

Chongqing Medical University - Department of Cardiology ( email )

China

Wen-Bin Wei

Sun Yat-sen University (SYSU)

135, Xingang Xi Road
Haizhu District
Guangzhou, Guangdong 510275
China

Yi Yan

Chinese Academy of Medical Sciences - Key Laboratory of Pulmonary Vascular Medicine

Beijing
China

Jing-Hui Li

Chinese Academy of Medical Sciences - Key Laboratory of Pulmonary Vascular Medicine

Beijing
China

Qian-Qian Liu

Chinese Academy of Medical Sciences - Key Laboratory of Pulmonary Vascular Medicine

Beijing
China

Sheng Li

ShanghaiTech University

393 Middle Huaxia Road, Pudong
Shanghai, 201210
China

Yong Wang

Capital Medical University

Beijing
China

Shu-Yang Zhang

Chinese Academy of Medical Sciences - Peking Union Medical College

NO. 9, Dongdan Santiao
Beijing, Dongcheng District
China

Xue Zhang

Chinese Academy of Medical Sciences - Center for Genetic Medicine

China

Zhi-Cheng Jing (Contact Author)

Chinese Academy of Medical Sciences - Key Laboratory of Pulmonary Vascular Medicine ( email )

Beijing
China

Chinese Academy of Medical Sciences - Peking Union Medical College ( email )

NO. 9, Dongdan Santiao
Beijing, Dongcheng District
China